Skip to content

Effect of Liu Wei Di Huang Wan on the Activities of CYP450s

Effect of a Traditional Chinese Medicine Liu Wei Di Huang Wan on the Activities of CYP2C19, CYP2D6 and CYP3A4 in Healthy Volunteers

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-11001624
Enrollment
Unknown
Registered
2011-10-24
Start date
2008-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Interventions

1:Liu Wei Di Huang Wan, bid, 4.8g, 14d

Sponsors

Institute of Clinical Pharmacology, Central South University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
19 Years to 21 Years

Inclusion criteria

Inclusion criteria: Healthy subjects with no past medical history and drug allergies, not taking any medication14 days before the clinical trial

Exclusion criteria

Exclusion criteria: Blood, urine, liver and kidney functions were normal, ECG and physical examination were normal

Design outcomes

Primary

MeasureTime frame
activity of CYP3A4;activity of CYP2D6;activity of CYP2C1;

Countries

China

Contacts

Public ContactDongsheng Ouyang
ouyangyj@163.com+86 13307313736

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026